For citations:

Mayorov A.Y., Drai R.V., Karonova T.L., Avdeeva O.I., Makarenko I.E., Koksharova E.O., Mishina E.Е., Sevastyanova Yu.А., Afonkina O.V. Evaluation of biosimilarity of RinGlar® (GEROPHARM LLC, Russia) and Lantus® (Sanofi-Aventis Deutschland GmbH, Germany) using the euglycemic hyperinsulinemic clamp technique in patients with type 1 diabetes: double-blind randomized clinical trial. Diabetes mellitus. 2020;23(4):304-315. (In Russ.) https://doi.org/10.14341/DM10095